ePRO BI1403-0008 與 AiCure 使用情況與統計
Boehringer Ingelheim ePRO BI1403-0008 is intended to collect patient reported outcomes relating to a clinical trial (BI Trial 1403-0008 – Brightline-1). Patients must be given accounts by a participating site in order to log in to the app.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
AiCure uses patented artificial intelligence (AI) on mobile devices to confirm medication ingestion.
Features:
Reminders, automated alerts, interactive guidance, video, audio recording and analysis in the background, remote data analysis, real-time feedback.
Monitoring:
The app will let your study/care coordinator know if you have not taken your medication.
Interactive Guidance:
The app provides interactive visual and audio guidance that automatically adjusts to your needs.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
ePRO BI1403-0008 VS. 
AiCure12月 28, 2024